Facebook
Twitter
LinkedIn
Forward
Making a Difference: Expediting Diagnosis of Ovarian Cancer
Live Webinar via Zoom
6:00 - 8:00 PM ET
Jointly Provided by Brown University and Rhode Island Department of Health
In collaboration with The Partnership to Reduce Cancer in Rhode Island, Women & Infants Hospital Program in Women's Oncology, University of Rhode Island, College of Nursing, Michigan Oncology Quality Consortium and Iowa Cancer Consortium
This roundtable discussion hosted by leading multidiscipline experts will review patient presentation, symptoms, diagnostic evaluation, physical exam, and indicators and benefits for gynecologic oncology referral. It will also illustrate the patient population at risk to carry a cancer genetic mutation and the importance of counseling for ovarian cancer predisposition and targeted treatment.
Historically, ovarian cancer was called the silent killer because symptoms were not thought to develop until the chance of cure was poor. However, recent studies have proven this untrue and have recognized that identifying early symptoms can be critical in order to improve outcomes. It has now been shown that the following new and/or persistent symptoms are likely to occur in women with ovarian cancer, and at times in patients with early stage disease: bloating; pelvic or abdominal pain; difficulty eating or feeling full quickly; and urinary symptoms (urgency or frequency).
The presenting symptoms are often mistaken for something else like irritable bowel syndrome, menopause, constipation, or indigestion and this results in delayed diagnosis. Many women ignore or downplay important symptoms that can be critical for an earlier diagnosis of ovarian cancer. Likewise, healthcare providers often do not recognize the urgency of evaluating symptoms and appropriate referral to a gynecologic oncologist improving overall prognosis and survival. Some patients may lack the most common symptoms of ovarian cancer but may have other or no presenting symptoms.
When a woman is diagnosed and treated in the earliest stages, the five-year survival rate is over 90 percent, Due to ovarian cancer’s nonspecific symptoms and lack of early detection tests, only about 15 percent of cases are identified early (stage I or II). If detected at stage III or higher, the five-year survival rate can be as low as 28 percent.
Target Audience
Physicians and Physician Specialists (gynecologists, gastroenterologists), Physician Assistants, Nurse Practitioners, Registered Nurses, Medical Students, Residents, Fellows and other allied healthcare professionals engaged in the care of women as well as insurers, policy makers, public health professionals, cancer advocacy organizations.
Learning Objectives
After participating in this webinar, the learner should be better able to:
- Identify the benefits of rapid referral of women with ovarian cancer to Gynecologic Oncologists.
- Recognize the factors that influence staging of ovarian cancer at diagnosis.
- Describe how expediting the process of differential diagnosis can improve overall outcomes.
- Appreciate the importance of cancer genetic testing and counseling and its relationship to obtaining a comprehensive cancer family history.
- Have access to tools to empower primary care providers and specialists to improve outcomes for women with ovarian cancer.
- Learn about other collaborative projects associated with this grant including RI’s Survivor’s Teaching Students® and projects completed through groups in Iowa and Michigan.
Additional Information
| Attachment | Size |
|---|---|
 Flyer | 121.09 KB |
| RIDOH's 2020 Ovarian Cancer Data Brief | 1.27 MB |
To access the RIDOH Ovarian Cancer Toolkit click the link below:
https://health.ri.gov/publications/toolkits/2020RI-Ovarian-Cancer
| Topic | Speaker |
6:00 - 6:05 pm | Welcome remarks | Nicole Alexander-Scott, MD, MPH |
6:05 - 6:15 pm | Survivor Story | Patient Survivor |
6:15 - 6:20 pm | Case Study (Intro) | Moderator: Teresa Paiva -Weed, JD |
6:20 - 6:50 pm | Best Patient Care for Earlier Ovarian Cancer Diagnosis – A Multidisciplinary Approach | Panelists: |
| ||
| ||
| ||
| ||
| ||
|
| |
6:50 - 6:55 pm | Survivor Story | Patient Survivor |
6:55 - 7:15 pm | Question & Answer Session | Moderator: Teresa Paiva Weed, JD |
7:15 - 7:45 pm | Multi-State Ovarian Cancer Initiative Project Outcomes | Introductions: (2 mins)
|
7:45 - 8:00pm
| Wrap up and Call to action Conclusions – where do we go from here? | Teresa Paiva Weed, JD & Joseph Dziobek, MSW |
Presenters
Nicole Alexander-Scott, MD, MPH
Director, Rhode Island Department of Health
Providence, RI
Bani Chander Roland, MD, FACG
Assistant Professor of Medicine, Clinician Educator
Warren Alpert Medical School of Brown University
Center for Women's Gastrointestinal Health
Women & Infants Hospital | Providence, RI
Don S. Dizon, MD, FACP, FASCO
Professor of Medicine (Research Scholar)
Warren Alpert Medical School of Brown University
Director of Women's Cancers | Lifespan Cancer Institute
Clinical Director, Gynecologic Medical Oncology and Director of Medical Oncology
Rhode Island Hospital | Providence, RI
Kristen Hubbard, MD
Internist, Coastal Medical
Providence, RI
Robert Legare, MD
Associate Professor, Clinical Medicine (Medical Oncology)
Yale School of Medicine
Medical Director, Smilow Cancer Hospital Care Center
Yale New Haven Health | Westerly, RI and Waterford, CT
Diane C. Martins, PhD, RN, FAAN
Professor, College of Nursing
University of Rhode Island | Kingston, RI
Matthew T. Oliver, MD
Assistant Professor of Obstetrics and Gynecology
Warren Alpert Medical School of Brown University
Program in Women's Oncology
Women & Infants Hospital | Providence, RI
M. Teresa Paiva-Weed, JD
President, Hospital Association of Rhode Island
Providence, RI
Audra Putt, MPH, CPH
Palliative Care Consultant (Public Health Consultant)
Michigan Department of Health and Human Services | Lansing, MI
Jennifer Scalia Wilbur, MS
Teaching Associate in Obstetrics and Gynecology
Warren Alpert Medical School of Brown University
Clinical Program Manager, Program in Women's Oncology
Cancer Genetics and Prevention Program
Women & Infants Hospital | Providence, RI
Kristen Weeks, BS
MD & PhD Candidate
University of Iowa | Iowa City, IA
Planning Committee
George Andoscia, MPH
Policy, Systems & Environmental Change Specialist
Comprehensive Cancer Control Program
Rhode Island Department of Health
Megan Daniel
Administrator for Community Partnerships
Partnership to Reduce Cancer in Rhode Island | Providence, RI
Linda Dziobek, RN
Cancer Survivor and Advocate | South Kingstown, RI
Joseph Dziobek, MSW
Director, Partnership to Reduce Cancer in RI
Providence, RI
Norma V. Hardy, MEd, CHES
Cancer Survivor | Providence, RI
Donna J. MacDonald, BSN, RN, OCN, CCM
RN-Case Manager - Oncology
Women & Infants Hospital | Providence, RI
Jennifer Maloney
Office of Continuing Medical Education
Warren Alpert Medical School of Brown University | Providence, RI
Diane C. Martins, PhD, RN, FAAN
Professor, College of Nursing
University of Rhode Island | Kingston, RI
Matthew T. Oliver, MD
Assistant Professor of Obstetrics and Gynecology
Warren Alpert Medical School of Brown University
Program in Women's Oncology
Women & Infants Hospital | Providence, RI
Jennifer Scalia Wilbur, MS
Teaching Associate in Obstetrics and Gynecology
Warren Alpert Medical School of Brown University
Clinical Program Manager, Program in Women's Oncology
Cancer Genetics and Prevention Program
Women & Infants Hospital | Providence, RI
C. Kelly Smith, MSW
Manager, Comprehensive Cancer Control Program
Rhode Island Department of Health
Providence, RI
Maria Sullivan
Director, Office of Continuing Medical Education
Warren Alpert Medical School of Brown University | Providence, RI
Siana Wood, RN, BSN, CDOE
Nurse Planner, Office of Continuing Medical Education
Warren Alpert Medical School of Brown University | Providence, RI
Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Warren Alpert Medical School of Brown University and the Rhode Island Department of Health. The Warren Alpert Medical School of Brown University is accredited by the ACCME to provide continuing medical education for physicians.
Nurses
This nursing continuing professional development activity was approved by the Northeast Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Social Workers
The above program has been approved in accordance with the Regulations of the Rhode Island Social Work Board of Licensure.
Available Credit
- 2.00 AMA PRA Category 1 Credit™The Warren Alpert Medical School of Brown University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 2.00 ANCCThis continuing nursing education activity was approved by the Northeast Multistate Division, an accredited provider by the American Nurses Credentialing Center’s Commission on Accreditation.
- 2.00 AttendanceParticipants will receive a Certificate of Attendance stating this program is designated for AMA PRA Category 1 Credit™. This credit is accepted by the AAPA and AANP.